OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Release Date
2022
(2)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses.
Not available
S-EPMC11523995
|
biostudies-literature
Cite
Identifying key components of a web-based long term care planning intervention for family caregivers of individuals with intellectual/developmental disabilities.
Not available
S-EPMC9313859
|
biostudies-literature
Cite
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Not available
S-EPMC8853032
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
